Apoptosome dysfunction in human cancer
- PMID: 15505412
- DOI: 10.1023/B:APPT.0000045786.98031.1d
Apoptosome dysfunction in human cancer
Abstract
Apoptosis is a cell suicide mechanism that enables organisms to control cell number and eliminate cells that threaten survival. The apoptotic cascade can be triggered through two major pathways. Extracellular signals such as members of the tumor necrosis factor (TNF) family can activate the receptor-mediated extrinsic pathway. Alternatively, stress signals such as DNA damage, hypoxia, and loss of survival signals may trigger the mitochondrial intrinsic pathway. In the latter, mitochondrial damage results in cytochrome c release and formation of the apoptosome, a multimeric protein complex containing Apaf-1, cytochrome c , and caspase-9. Once bound to the apoptosome, caspase-9 is activated, and subsequently triggers a cascade of effector caspase activation and proteolysis, leading to apoptotic cell death. Recent efforts have led to the identification of multiple factors that modulate apoptosome formation and function. Alterations in the expression and/or function of these factors may contribute to the pathogenesis of cancer and resistance of tumor cells to chemotherapy or radiation. In this review we discuss how disruption of normal apoptosome formation and function may lead or contribute to tumor development and progression.
Similar articles
-
Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex.Hepatology. 2000 Oct;32(4 Pt 1):750-60. doi: 10.1053/jhep.2000.18329. Hepatology. 2000. PMID: 11003619
-
Targeting the apoptosome for cancer therapy.Clin Cancer Res. 2009 Jan 15;15(2):420-4. doi: 10.1158/1078-0432.CCR-08-1172. Clin Cancer Res. 2009. PMID: 19147745 Review.
-
Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance.Cell Death Differ. 2008 Mar;15(3):443-52. doi: 10.1038/sj.cdd.4402265. Epub 2007 Nov 2. Cell Death Differ. 2008. PMID: 17975549 Review.
-
Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.Cancer Res. 2002 Feb 1;62(3):924-31. Cancer Res. 2002. PMID: 11830553
-
Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.Cancer Res. 2003 Feb 15;63(4):831-7. Cancer Res. 2003. PMID: 12591734
Cited by
-
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy.Cancers (Basel). 2022 Nov 9;14(22):5500. doi: 10.3390/cancers14225500. Cancers (Basel). 2022. PMID: 36428594 Free PMC article.
-
Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.Cancer Sci. 2012 Aug;103(8):1451-9. doi: 10.1111/j.1349-7006.2012.02323.x. Epub 2012 Jun 18. Cancer Sci. 2012. PMID: 22568453 Free PMC article.
-
Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway.J Biol Chem. 2008 Mar 28;283(13):8624-33. doi: 10.1074/jbc.M707860200. Epub 2008 Jan 23. J Biol Chem. 2008. PMID: 18218619 Free PMC article.
-
Caspase polymorphisms and genetic susceptibility to multiple myeloma.Hematol Oncol. 2008 Sep;26(3):148-51. doi: 10.1002/hon.852. Hematol Oncol. 2008. PMID: 18381704 Free PMC article.
-
Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma.Oncotarget. 2016 Apr 19;7(16):21287-97. doi: 10.18632/oncotarget.7116. Oncotarget. 2016. PMID: 26848773 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
